MIRA Pharmaceuticals, Inc. (MIRA) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q1'22 | Q1'21 |
|---|
| Total Current Assets | 9.43M | 11.06M | 7.6M | 832.88K | 1.36M | 2.89M | 4.23M | 2.93M | 3.71M | 4.86M | 6.07M | 420.72K | 251.07K | 494.4K | 2.22M | 0 |
| Cash & Short-Term Investments | 9.41M | 6.35M | 2.64M | 730.48K | 1.21M | 2.83M | 4.14M | 2.82M | 3.53M | 4.6M | 5.87M | 24.82K | 1.35K | 350.98K | 2.12M | 0 |
| Cash Only | 4.82M | 6.35M | 2.64M | 730.48K | 1.21M | 2.83M | 4.14M | 2.82M | 3.53M | 4.6M | 5.87M | 24.82K | 1.35K | 350.98K | 2.12M | 0 |
| Short-Term Investments | 4.59M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 35.44K | 35.44K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 21.75K | 4.71M | 4.92M | -35.44K | 0 | 0 | 0 | 0 | 0 | 11.86K | 0 | 353.37K | 189.69K | 143.43K | 100K | 0 |
| Total Non-Current Assets | 35.44K | 35.44K | 35.44K | 35.44K | 35.44K | 35.44K | 35.44K | 83.17K | 94.76K | 74.21K | 2.95M | 3.4M | 146.51K | 363.67K | 818.04K | 0 |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.27K | 5.06K | 114.36K | 132.33K | 146.51K | 363.67K | 194.19K | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 35.44K | 35.44K | 35.44K | 35.44K | 0 | 0 | 0 | 50K | 50K | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 35.44K | 35.44K | 35.44K | 0 | 0 | 0 | 0 | 83.17K | 93.49K | 69.15K | 2.78M | 3.22M | 0 | 0 | 623.85K | 0 |
| Total Assets | 9.46M | 11.09M | 7.63M | 868.32K | 1.4M | 2.92M | 4.27M | 3.02M | 3.81M | 4.93M | 9.02M | 3.83M | 397.58K | 858.07K | 3.04M | 0 |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 575.82% | 279.52% | 78.91% | -71.21% | -63.23% | -40.74% | -52.69% | -21.16% | 857.99% | 474.83% | - | - | -86.93% | - | - | - |
| Total Current Liabilities | 114.76K | 702.07K | 83.93K | 298.46K | 106.17K | 723.35K | 692.83K | 796.61K | 652.01K | 558.1K | 868.37K | 2.58M | 2.12M | 1.37M | 534.26K | 0 |
| Accounts Payable | 0 | 0 | 83.93K | 298.46K | 100.67K | 723.35K | 692.83K | 782.14K | 636.26K | 538.56K | 510.69K | 645.14K | 918.62K | 905.55K | 210.14K | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.8M | 219.54K | 133.06K | 243.06K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 114.76K | 702.07K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 268.88K | 0 | 685.46K | 0 | 0 | 0 |
| Current Ratio | 82.16x | 15.75x | 90.53x | 2.79x | 12.86x | 3.99x | 6.11x | 3.68x | 5.70x | 8.70x | 6.99x | 0.16x | 0.12x | 0.36x | 4.16x | - |
| Quick Ratio | 82.16x | 15.75x | 90.53x | 2.79x | 12.86x | 3.99x | 6.11x | 3.68x | 5.70x | 8.70x | 6.99x | 0.16x | 0.12x | 0.36x | 4.16x | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34.53K | 51.47K | 68.21K | 84.27K | 136.23K | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34.53K | 51.47K | 68.21K | 84.27K | 136.23K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 114.76K | 702.07K | 83.93K | 298.46K | 106.17K | 723.35K | 692.83K | 796.61K | 652.01K | 558.1K | 902.9K | 2.63M | 2.19M | 1.45M | 670.49K | 0 |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.27K | 5.06K | 108.86K | 1.93M | 360.55K | 491.23K | 431.76K | 0 |
| Net Debt | -4.82M | -6.35M | -2.64M | -730.48K | -1.21M | -2.83M | -4.14M | -2.82M | -3.53M | -4.6M | -5.76M | 1.9M | 359.2K | 140.25K | -1.69M | 0 |
| Debt / Equity | - | - | - | - | - | - | - | - | 0.00x | 0.00x | 0.01x | 1.61x | - | - | 0.18x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | -1.12x | -7.39x | -3.28x | -810.28x | -763.14x | -380.94x | - |
| Total Equity | 9.35M | 10.39M | 7.55M | 569.86K | 1.29M | 2.2M | 3.57M | 2.22M | 3.16M | 4.37M | 8.12M | 1.2M | -1.79M | -596.23K | 2.37M | 0 |
| Equity Growth % | 622.39% | 372.4% | 111.25% | -74.32% | -59% | -49.71% | -55.96% | 85.44% | 276.41% | 833.67% | - | - | -175.5% | - | - | - |
| Book Value per Share | 0.22 | 0.44 | 0.39 | 0.03 | 0.08 | 0.14 | 0.24 | 0.15 | 0.16 | 0.30 | 0.55 | 0.08 | -0.12 | -0.04 | 0.16 | - |
| Total Shareholders' Equity | 9.35M | 10.39M | 7.55M | 569.86K | 1.29M | 2.2M | 3.57M | 2.22M | 3.16M | 4.37M | 8.12M | 1.2M | -1.79M | -596.23K | 2.37M | 0 |
| Common Stock | 4.2K | 4.19K | 3.95K | 1.74K | 1.68K | 1.66K | 1.63K | 1.48K | 1.48K | 1.48K | 1.48K | 6.66K | 6.66K | 6.66K | 6.54K | 0 |
| Retained Earnings | -40.73M | -39.58M | -33.6M | -32.46M | -30.92M | -29.14M | -26.74M | -24.69M | -23M | -21.29M | -15.5M | -11.91M | -10.64M | -9.3M | -3.72M | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -135K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |